GeoPharma Income Statement
View: Annual | Quarterly
| Quarter Ending Sep 08 |
Quarter Ending Jun 08 |
Quarter Ending Mar 08 |
Quarter Ending Dec 07 |
Quarter Ending Sep 07 |
|
|---|---|---|---|---|---|
| Revenue | 16.0 | 20.0 | 23.9 | 18.2 | 6.0 |
| Cost of Goods Sold | 13.4 | 16.3 | 19.3 | 14.7 | 4.8 |
| Gross Profit | 2.7 | 3.7 | 4.6 | 3.6 | 1.2 |
| Gross Profit Margin | 16.8% | 18.7% | 19.3% | 19.6% | 20.4% |
| SG&A Expense | 6.0 | 5.8 | 6.6 | 5.1 | 3.3 |
| Depreciation & Amortization | 1.1 | 1.0 | 0.8 | 0.8 | 0.9 |
| Operating Income | (4.4) | (3.0) | (2.8) | (2.3) | (2.9) |
| Operating Margin | -- | -- | -- | -- | -- |
| Nonoperating Income | 0.0 | 0.0 | 0.0 | 0.0 | (0.0) |
| Nonoperating Expenses | 0.5 | 0.5 | 0.3 | 0.2 | (0.1) |
| Income Before Taxes | (4.9) | (3.5) | (3.0) | (2.5) | (2.8) |
| Income Taxes | (1.0) | (0.7) | (0.1) | (0.7) | (0.9) |
| Net Income After Taxes | (3.9) | (2.8) | (3.0) | (1.8) | (1.9) |
| Continuing Operations | (3.8) | (2.6) | (2.7) | (1.6) | (1.7) |
| Discontinued Operations | -- | -- | 0.0 | 0.0 | 0.0 |
| Total Operations | (3.8) | (2.6) | (2.7) | (1.6) | (1.7) |
| Total Net Income | (3.8) | (2.6) | (2.7) | (1.6) | (1.7) |
| Net Profit Margin | -- | -- | -- | -- | -- |
| Diluted EPS from Total Net Income ($) | (0.24) | (0.19) | (0.20) | (0.12) | (0.16) |
| Dividends per Share | -- | -- | -- | -- | -- |





